Astrana Health Inc (ASTH)

Profitability ratios

Return on sales

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Gross profit margin 4.36% 25.74% 49.60% 51.69% 54.21% 32.61% 26.20% 29.21% 32.87% 35.96% 34.41% 34.79% 42.90% 41.72% 41.87% 39.71% 32.49% 36.36% 6.76% 16.94%
Operating profit margin 6.46% 6.17% 7.65% 8.68% 8.26% 9.13% 9.01% 10.14% 11.93% 12.71% 16.15% 15.07% 12.37% 10.33% 8.39% 5.04% 6.40% 5.79% 4.83% 14.05%
Pretax margin 6.62% 6.76% 6.58% 7.39% 7.03% 7.53% 8.28% 8.35% 12.03% 13.32% 15.50% 15.67% 13.68% 12.06% 10.29% 7.96% 4.66% 3.98% 2.02% 5.24%
Net profit margin 4.36% 4.43% 3.38% 3.54% 3.66% 4.00% 5.92% 7.62% 8.56% 9.39% 9.32% 7.48% 5.93% 4.86% 4.42% 2.84% 2.88% 2.52% 0.88% 1.95%

The gross profit margin of Astrana Health Inc has fluctuated significantly over the analyzed periods, ranging from a low of 4.36% to a high of 54.21%. This indicates varying levels of efficiency in managing production costs and generating sales revenue. The company's operating profit margin has shown less volatility, with a range from 5.04% to 16.15%, suggesting relatively stable operational efficiency in controlling operating expenses.

On the other hand, the pretax margin has displayed some variability, moving between 3.98% and 15.67%. This metric reflects the company's ability to generate profits before accounting for taxes, showing fluctuations in profitability levels. Lastly, the net profit margin, which signifies the company's bottom-line profitability after all expenses are deducted, has ranged from 0.88% to 9.39%. This indicates that Astrana Health Inc has experienced varying levels of success in managing its overall expenses and achieving net profits.

Overall, the performance of Astrana Health Inc in terms of profitability ratios has been volatile, with fluctuations seen in gross, operating, pretax, and net profit margins across the analyzed periods. This variability suggests that the company has faced challenges in consistently controlling costs and improving overall profitability.


Return on investment

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Operating return on assets (Operating ROA) 7.53% 9.07% 9.42% 10.91% 10.12% 10.79% 9.96% 10.20% 11.12% 11.52% 13.98% 11.83% 11.61% 9.85% 8.05% 4.59% 5.53% 4.45% 3.13% 12.32%
Return on assets (ROA) 5.09% 6.51% 4.16% 4.45% 4.49% 4.73% 6.54% 7.66% 7.98% 8.50% 8.07% 5.87% 5.57% 4.63% 4.24% 2.58% 2.49% 1.94% 0.57% 1.71%
Return on total capital 11.26% 12.46% 12.83% 14.22% 13.01% 12.90% 13.07% 12.49% 16.53% 23.79% 19.85% 20.12% 20.21% 18.44% 20.20% 16.02% 8.56% 6.38% 2.67% 14.56%
Return on equity (ROE) 9.55% 9.89% 7.52% 8.08% 8.12% 8.42% 12.08% 15.19% 15.57% 16.18% 16.15% 13.10% 13.45% 11.45% 15.12% 10.40% 9.15% 7.37% 2.25% 5.23%

Astrana Health Inc's profitability ratios have fluctuated over the past few quarters.

1. Operating return on assets (Operating ROA) has ranged from 7.53% to 13.98% over the last two years, with a peak in Q3 2021. This ratio measures the efficiency of utilizing assets to generate operating income.

2. Return on assets (ROA) has varied from 2.49% to 8.50% during the same period. It indicates the company's ability to generate profits from its total assets.

3. Return on total capital has fluctuated between 6.38% and 23.79%, peaking in Q4 2021. This ratio reflects the return the company generates on all invested capital.

4. Return on equity (ROE) has ranged from 5.23% to 16.18% over the past two years. This ratio demonstrates the return the company generates on shareholders' equity.

Overall, while there have been fluctuations in profitability ratios, Astrana Health Inc has generally maintained a moderate level of profitability relative to its assets, capital, and equity. The company should continue to monitor and improve these ratios to ensure sustained profitability and shareholder value.